July 12, 2026
City of Hope to Evaluate Quest Diagnostics’ Haystack MRD® for Guiding Patient Management in Multiple Cancers
B Fourteen City of Hope sites across the U.S. participating in research using the Haystack MRD ctDNA Test in patients with breast, colorectal, ovarian, and…

